FORTUNE -- Private equity firm Clayton Dubilier & Rice today said that it has completed its previously-announced acquisition of a majority stake in PharMEDium from Oak Investment Partners and Baird Capital.
No financial terms were disclosed, but Fortune has learned that the deal was done at around a $900 million enterprise valuation.
For Oak this represents around a 6x return on its 2007 investment, when it paid around $67 million to acquire an equity stake from Baird (which retained part of its position).
PharMEDium is a Lake Forrest, Ill.–based provider of hospital pharmacy sterile compounding services.
Sign up for Dan Primack's daily email newsletter on deals and deal-makers: GetTermSheet.com
Is Hertz better off today than it was seven years ago?
FORTUNE -- Hertz's private equity sponsors sold their remaining shares earlier this week, fully existing the company more than 7 years after buying it from Ford Motor Co. (F).
That deal came in the midst of private equity's "golden age," and was one of that era's most-criticized transactions. Not so much the original purchase, but rather the subsequent $1 billion dividend MOREDan Primack - May 9, 2013 3:35 PM ET
|The medical marijuana ad that never aired, despite contrary media headlines|
|China to fight pollution with drones|
|2 million students missing out on college aid|
|Boeing reports wing cracks on Dreamliners|
|Boeing to end pension plans for non-union employees|